Assessing diagnostic delay in Ewing sarcoma: A single tertiary center analysis
Folia Medica · 2025
DOI: 10.3897/folmed.67.e153324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Medica, 2025. Verfasst von Yordan S Ivanov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of Sofia, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Bone Neoplasms, Delayed Diagnosis. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Ewing sarcoma is a rare and highly aggressive primary malignant bone tumor. Early diagnosis is difficult, especially in the early stages of the disease, which often results in delays in diagnosis.
Aim
The aim of this study was to determine the extent of diagnostic delays in patients with Ewing sarcoma in Bulgaria and their relationship with clinical and demographic factors. Materials and methods : This study examined 40 patients diagnosed and treated with Ewing sarcoma at a single tertiary care unit in Sofia, Bulgaria. The cohort consisted of 26 males and 14 females with a mean age of 18 years (range 6–36 years). We assessed the following patient criteria: time from initial symptoms to final histologic diagnosis; first doctor visit; diagnostic procedures performed at the first doctor visit; and treatment conducted before histologic diagnosis. We performed statistical analyses of the data using a t-test, chi-squared test, and logistic regression analysis.
Results
The mean diagnostic delay for our patients was 182 days (range 30–730 days), or approximately six months. Statistical analysis revealed that the diagnostic delay did not have a statistically significant effect on overall patient survival ( p >0.05). Of all the analyzed variables, only tumor stage had a statistically significant impact on overall survival.
Conclusion
Patients with Ewing sarcoma in Bulgaria experience a significant diagnostic delay, highlighting issues in the disease’s diagnostic process. However, diagnostic delay did not significantly impact overall survival, suggesting that tumor biology and stage are more critical prognostic factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical University of Sofia, Sofia, Bulgaria.
ORCID-Profile: Yordan S Ivanov
Zitieren
APA
Ivanov, Y. S., Ivanov, I. V., & Atanasova-Ivanova, K. A. (2025). Assessing diagnostic delay in Ewing sarcoma: A single tertiary center analysis. Folia Medica. https://doi.org/10.3897/folmed.67.e153324
Vancouver
Ivanov YS, Ivanov IV, Atanasova-Ivanova KA. Assessing diagnostic delay in Ewing sarcoma: A single tertiary center analysis. Folia Medica. 2025. doi:10.3897/folmed.67.e153324
BibTeX
@article{Ivanov2025,
author = {Ivanov, Yordan S and Ivanov, Ivo V and Atanasova-Ivanova, Karina A},
title = {Assessing diagnostic delay in Ewing sarcoma: A single tertiary center analysis},
journal = {Folia Medica},
year = {2025},
doi = {10.3897/folmed.67.e153324}
}
EUVIMED